TY  - GEN
AU  - Buysmann,S
AU  - Hack,C E
AU  - van Diepen,F N
AU  - Surachno,J
AU  - ten Berge,I J
TI  - Administration of OKT3 as a two-hour infusion attenuates first-dose side effects
SN  - 0041-1337
PY  - 1998///0112
KW  - Anaphylatoxins
KW  - metabolism
KW  - Animals
KW  - Complement Activation
KW  - drug effects
KW  - Complement C3a
KW  - analogs & derivatives
KW  - Drug Administration Schedule
KW  - Dyspnea
KW  - chemically induced
KW  - Infusions, Intravenous
KW  - Kidney Transplantation
KW  - adverse effects
KW  - Mice
KW  - Muromonab-CD3
KW  - administration & dosage
KW  - Neutrophil Activation
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/00007890-199712150-00024
ER  -